Patrick Barton

2.5k total citations
34 papers, 1.7k citations indexed

About

Patrick Barton is a scholar working on Pharmacology, Molecular Biology and Spectroscopy. According to data from OpenAlex, Patrick Barton has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 13 papers in Molecular Biology and 13 papers in Spectroscopy. Recurrent topics in Patrick Barton's work include Pharmacogenetics and Drug Metabolism (14 papers), Analytical Chemistry and Chromatography (11 papers) and Computational Drug Discovery Methods (11 papers). Patrick Barton is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Analytical Chemistry and Chromatography (11 papers) and Computational Drug Discovery Methods (11 papers). Patrick Barton collaborates with scholars based in United Kingdom, United States and Belgium. Patrick Barton's co-authors include Rupert P. Austin, Mark C. Wenlock, Robert J. Riley, A. M. Davis, Paul D. Leeson, Scott L. Cockroft, Adam Lucas, Michael I. Page, K. Grime and Dermot F. McGinnity and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Patrick Barton

34 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Barton United Kingdom 20 678 579 530 408 313 34 1.7k
Rupert P. Austin United Kingdom 17 602 0.9× 516 0.9× 627 1.2× 549 1.3× 367 1.2× 29 1.8k
Ismael Zamora Spain 26 831 1.2× 766 1.3× 568 1.1× 377 0.9× 432 1.4× 59 1.9k
Susanne Winiwarter Sweden 19 510 0.8× 482 0.8× 261 0.5× 439 1.1× 293 0.9× 40 1.6k
Patrizia Crivori Italy 15 674 1.0× 670 1.2× 233 0.4× 314 0.8× 346 1.1× 27 1.6k
Fabio Broccatelli United States 18 455 0.7× 435 0.8× 328 0.6× 404 1.0× 198 0.6× 30 1.5k
Zhengyin Yan United States 26 803 1.2× 278 0.5× 587 1.1× 369 0.9× 296 0.9× 59 1.8k
Emre M. Isin United States 18 647 1.0× 272 0.5× 897 1.7× 328 0.8× 159 0.5× 38 1.8k
James H. Wikel United States 19 734 1.1× 730 1.3× 532 1.0× 518 1.3× 317 1.0× 38 1.8k
D. F. V. Lewis United Kingdom 28 585 0.9× 493 0.9× 991 1.9× 485 1.2× 265 0.8× 58 2.6k
Sandeep Modi United Kingdom 26 1.2k 1.7× 527 0.9× 987 1.9× 379 0.9× 409 1.3× 67 2.5k

Countries citing papers authored by Patrick Barton

Since Specialization
Citations

This map shows the geographic impact of Patrick Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Barton more than expected).

Fields of papers citing papers by Patrick Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Barton. The network helps show where Patrick Barton may publish in the future.

Co-authorship network of co-authors of Patrick Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Barton. A scholar is included among the top collaborators of Patrick Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Barton. Patrick Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aronica, Eleonora, et al.. (2024). Spatial omics reveals molecular changes in focal cortical dysplasia type II. Neurobiology of Disease. 195. 106491–106491. 8 indexed citations
2.
Cox, Benoit, Patrick Barton, Reiner Class, et al.. (2022). Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation. SHILAP Revista de lepidopterología. 7. 100054–100054. 17 indexed citations
3.
Isin, Emre M., et al.. (2022). Multimodal molecular imaging in drug discovery and development. Drug Discovery Today. 27(8). 2086–2099. 36 indexed citations
4.
Wenlock, Mark C., et al.. (2021). Prediction of Chameleonic Efficiency. ChemMedChem. 16(17). 2669–2685. 19 indexed citations
5.
Williamson, Beth, et al.. (2018). Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery. Drug Metabolism and Disposition. 46(8). 1169–1178. 9 indexed citations
6.
7.
Barton, Patrick & Robert J. Riley. (2015). A new paradigm for navigating compound property related drug attrition. Drug Discovery Today. 21(1). 72–81. 28 indexed citations
8.
Soars, Matthew G., et al.. (2014). Application of anin vitroOAT assay in drug design and optimization of renal clearance. Xenobiotica. 44(7). 657–665. 7 indexed citations
9.
Barton, Patrick, Keith Bowers, Peter S. Gilmour, et al.. (2012). Scaffold-hopping with zwitterionic CCR3 antagonists: Identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092. Bioorganic & Medicinal Chemistry Letters. 22(21). 6694–6699. 17 indexed citations
10.
Barton, Patrick, Keith Bowers, Richard H. Evans, et al.. (2012). The discovery of CCR3/H1 dual antagonists with reduced hERG risk. Bioorganic & Medicinal Chemistry Letters. 22(21). 6688–6693. 13 indexed citations
11.
Wenlock, Mark C., et al.. (2011). A Method for Measuring the Lipophilicity of Compounds in Mixtures of 10. SLAS DISCOVERY. 16(3). 348–355. 54 indexed citations
12.
Wenlock, Mark C., Patrick Barton, & Tim Luker. (2011). Lipophilicity of acidic compounds: Impact of ion pair partitioning on drug design. Bioorganic & Medicinal Chemistry Letters. 21(12). 3550–3556. 9 indexed citations
13.
Wenlock, Mark C., Patrick Barton, & Rupert P. Austin. (2011). A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril. Journal of Pharmaceutical and Biomedical Analysis. 55(3). 385–390. 8 indexed citations
14.
Paine, Stuart W., Patrick Barton, James Bird, et al.. (2010). A rapid computational filter for predicting the rate of human renal clearance. Journal of Molecular Graphics and Modelling. 29(4). 529–537. 34 indexed citations
15.
Austin, Rupert P., et al.. (2005). The Thermodynamics of the Partitioning of Ionizing Molecules Between Aqueous Buffers and Phospholipid Membranes. Pharmaceutical Research. 22(10). 1649–1657. 26 indexed citations
16.
Austin, Rupert P., et al.. (2004). THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES. Drug Metabolism and Disposition. 33(3). 419–425. 140 indexed citations
17.
Barton, Patrick, Christopher A. Hunter, Timothy J. Potter, Simon P. Webb, & Nicholas H. Williams. (2002). Transmembrane Signalling. Angewandte Chemie International Edition. 41(20). 3878–3881. 57 indexed citations
18.
Austin, Rupert P., Patrick Barton, Scott L. Cockroft, Mark C. Wenlock, & Robert J. Riley. (2002). The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical Properties. Drug Metabolism and Disposition. 30(12). 1497–1503. 320 indexed citations
19.
Austin, Rupert P., et al.. (1998). The Effect of lonic Strength on Liposome–Buffer and 1-Octanol–Buffer Distribution Coefficients. Journal of Pharmaceutical Sciences. 87(5). 599–607. 49 indexed citations
20.
Barton, Patrick, A. M. Davis, Peter J. H. Webborn, & Dennis J. McCarthy. (1997). Drug-Phospholipid Interactions. 2. Predicting the Sites of Drug Distribution Using n-Octanol/Water and Membrane/Water Distribution Coefficients. Journal of Pharmaceutical Sciences. 86(9). 1034–1039. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rupert P. Austin Breakdown of academic impact, for papers by Ismael Zamora Breakdown of academic impact, for papers by Susanne Winiwarter Breakdown of academic impact, for papers by Patrizia Crivori Breakdown of academic impact, for papers by Fabio Broccatelli Breakdown of academic impact, for papers by Zhengyin Yan Breakdown of academic impact, for papers by Emre M. Isin Breakdown of academic impact, for papers by James H. Wikel Breakdown of academic impact, for papers by D. F. V. Lewis Breakdown of academic impact, for papers by Sandeep Modi
Rankless by CCL
2026